BioMarin Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
09.10.25
/
50%
€46.83
Target price
09.10.26
€102.23
Performance (%)
-0.70%
Price
10.04.26
€46.50
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc. is nearly unchanged. This prediction currently runs until 09.10.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.367% | -3.367% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at JPMorgan Chase & Co. from $116.00 to $119.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.32
14.07.25
14.07.25
€96.68
14.07.26
14.07.26
-7.59%
10.04.26
10.04.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€61.40
30.10.24
30.10.24
€100.36
30.10.25
30.10.25
-26.91%
31.10.25
31.10.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€108.11
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25